Chimerix antiviral to be tested in West African Ebola trial

November 13, 2014 6:02 PM

1 0

(Reuters) - Chimerix Inc said its experimental broad-spectrum antiviral was one of two agents to be tested in a trial in confirmed Ebola patients in West Africa.

Chimerix and the University of Oxford are in process of finalizing an agreement to supply the drug, brincidofovir, for the study.

Also read: Merck's antiviral drug meets main goal in late-stage trial

Read more

To category page